Journal Article Summary

The article investigates a new method for quickly detecting the pandemic influenza A (H1N1) 2009 virus and identifying a specific mutation associated with resistance to the antiviral drug oseltamivir. This topic is significant because rapid identification of this virus and its resistant strains is crucial for effective patient management and public health responses during influenza outbreaks. As the pandemic unfolds, having reliable testing methods can help in controlling the spread of the virus and ensuring that patients receive appropriate treatment.

The researchers evaluated two new reverse transcriptase polymerase chain reaction (RT-PCR) tests on 684 throat swabs from individuals suspected of having the virus. They found that 121 samples tested positive for the pandemic influenza A/H1N1 virus using at least two of the three RT-PCR assays, with no cases of oseltamivir resistance detected among the samples. The tests demonstrated high sensitivity and specificity, making them suitable for clinical use in identifying the virus and screening for the H275Y mutation linked to antiviral resistance.

However, the study has limitations, including the potential for mismatches in the primer and probe regions due to changes in the virus over time, which could affect the accuracy of the tests. Patients should be aware that while these tests can quickly identify the virus and its resistance patterns, they should discuss any concerns about influenza treatment and testing with their healthcare provider. This conversation is important to ensure that patients receive the most effective care based on their specific circumstances and the evolving nature of the virus.

Medical Safety Note

This journal article summary is provided for educational purposes only and is not medical advice. Always consult a licensed healthcare professional before starting, stopping, or changing any medication.

Article Cited

  1. van der Vries E., Jonges M., Herfst S., Maaskant J., Van der Linden A., Guldemeester J., Aron G.I., Bestebroer T.M., et al.. Evaluation of a rapid molecular algorithm for detection of pandemic influenza A (H1N1) 2009 virus and screening for a key oseltamivir resistance (H275Y) substitution in neuraminidase. Journal of Clinical Virology 2010. DOI: 10.1016/j.jcv.2009.09.030. PMID: 19857993. PMCID: PMC7185517.

Featured Pill Pals Product

Pill Pals® is THE Express Pharmacy. Our Nationwide Pharmacy Network was created with the mission of helping you make SENSE of your meds™. As a Pharmacy Benefits Management organization, Pill Pals® gives patients the best cash prices on all meds. Pill Pals® is part of The Health Pals® Company (Health Pals®, Med Pals®, Skin Pals® etc), a vertically integrated Healthcare System that provides cost effective Medical and Pharmacy services to Employers, Patients, and more. For more information, please email [email protected]